Cross-fund · 5 holders
LCTX
LINEAGE CELL THERAPEUTICS IN
CUSIP 53566P109
5
Tracked holders
$31.7M
Aggregate value
19,541,018
Shares
5
Active funds
Funds holding LCTX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $16.1M | — | +637,346 | +7.1% |
| Millennium | Multi-Strategy | Q1 2026 | $8.8M | — | +3,450,955 | +163.5% |
| BlackRock | Institutional | Q1 2026 | $6.1M | — | +30,644 | +0.8% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $480,894 | — | +144,955 | +90.9% |
| Citadel | Multi-Strategy | Q1 2026 | $262,672 | — | -367,504 | -68.9% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.